Biotech Digest – XENT Gets FDA Approval, AGN Announces Acquisition, IONS Licenses Product

Intersect ENT Inc. reported the FDA approval for its SINUVA implant, designed to be used for treating recurrent nasal polyps in patients who have had previous ethmoid sinus surgery.